Premium
High‐priced drugs for multiple sclerosis and the medical economy in Japan
Author(s) -
Shimizu Yuko
Publication year - 2017
Publication title -
clinical and experimental neuroimmunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.297
H-Index - 15
ISSN - 1759-1961
DOI - 10.1111/cen3.12424
Subject(s) - multiple sclerosis , medicine , european union , disease , intensive care medicine , business , international trade , psychiatry , pathology
The high cost of medicines used to treat neurological diseases has received considerable attention in recent years. Disease‐modifying drugs for multiple sclerosis are expensive, and the cost‐effectiveness of these drugs has been discussed in the USA and the European Union. In Japan, the cost of multiple sclerosis therapies has increased gradually.